Features Hepatitis C in Prisons – Key Takeaways from INHSU 2023 According to UNODC data, one in four people in prison are living with hepatitis C. This year, at the International… 28 November 2023
Features Increasing opioid agonist treatment (OAT) coverage globally At the INHSU 2023 policy day in Geneva, Switzerland – part of our annual conference – policymakers, practitioners, community members,… 27 November 2023
Features INHSU 2023 – key takeaways from our rapporteurs Each year, to conclude the International Conference on Health and Hepatitis in Substance Users, we welcome experts to close the… 27 November 2023
News INHSU wins international innovation award for hepatitis C toolkit project The International Network on Health and Hepatitis in Substance Users (INHSU) has been awarded gold in the Innovation Category at… 23 November 2023
News INHSU Welcomes Louise Hansford as new board member for 2023-2026 Term Louise Hansford has been elected to the INHSU board for the 2023-2026 term, alongside the re-election of Jason Grebely as… 23 November 2023
Events Webinar: Lessons from the U.S. and Australia’s hepatitis C elimination strategies On December 12, from 4-5:30 pm EST, in partnership with CATIE – Canada’s source for HIV and hepatitis C information… 15 November 2023
Events Webinar: Is this the real(ist) method you should be using in your research? On Tuesday, 12 September 2023, the INHSU Early-Mid-Career Researchers Special Interest Group (INHSU EMCR) hosted its second INHSU Conversations webinar,… 13 November 2023
News Historic step forward for safer drug consumption site in Glasgow At INHSU 2022 in Glasgow, Scotland, we hosted a policy day focussed on the benefits of supervised consumption sites (SCS)…. 19 September 2023
Events Webinar: Is this the real(ist) method you should be using in your research? Join us for our latest INHSU Conversations Webinar, organised by our Early-Mid-Career Researcher Special Interest Group (INHSU EMCR), to discuss… 31 July 2023